A recent study reported benefits of CAR T cell therapy combined with an oncolytic adenovirus and a helper-dependent adenoviral vector encoding IL-12 and a PD-L1 blocking minibody against pancreatic cancer xenografts (66). This evidence concerns the gene CD274 and familial pancreatic carcinoma.